These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1044 related articles for article (PubMed ID: 25781605)
1. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes. He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605 [TBL] [Abstract][Full Text] [Related]
2. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy. Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219 [TBL] [Abstract][Full Text] [Related]
3. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes. Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094 [TBL] [Abstract][Full Text] [Related]
4. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma. Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122 [TBL] [Abstract][Full Text] [Related]
5. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy. Wu SG; Sun JY; Zhou J; Li FY; Zhou H; Lin Q; Lin HX; Bao Y; He ZY Radiat Oncol; 2014 Dec; 9():284. PubMed ID: 25511525 [TBL] [Abstract][Full Text] [Related]
6. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis. Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy]. Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696 [TBL] [Abstract][Full Text] [Related]
8. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation. Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454 [TBL] [Abstract][Full Text] [Related]
10. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer]. Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291 [No Abstract] [Full Text] [Related]
11. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289 [TBL] [Abstract][Full Text] [Related]
12. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases. Wu SP; Tam M; Shaikh F; Lee A; Chun J; Schnabel F; Guth A; Adams S; Schreiber D; Oh C; Gerber NK Ann Surg Oncol; 2018 Sep; 25(9):2620-2631. PubMed ID: 29987606 [TBL] [Abstract][Full Text] [Related]
13. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy]. Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235 [No Abstract] [Full Text] [Related]
14. Heterogeneity in Outcomes of Pathologic T1-2N1 Breast Cancer After Mastectomy: Looking Beyond Locoregional Failure Rates. Bazan JG; Majithia L; Quick AM; Wobb JL; Terando AM; Agnese DM; Farrar W; White JR Ann Surg Oncol; 2018 Aug; 25(8):2288-2295. PubMed ID: 29916008 [TBL] [Abstract][Full Text] [Related]
15. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998 [TBL] [Abstract][Full Text] [Related]
16. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence? Mamtani A; Patil S; Stempel MM; Morrow M Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423 [TBL] [Abstract][Full Text] [Related]
17. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era. Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722 [TBL] [Abstract][Full Text] [Related]
18. Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy. Lai SF; Chen YH; Kuo WH; Lien HC; Wang MY; Lu YS; Lo C; Kuo SH; Cheng AL; Huang CS Ann Surg Oncol; 2016 Nov; 23(12):3860-3869. PubMed ID: 27436202 [TBL] [Abstract][Full Text] [Related]
19. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer. Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555 [TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]